Alpha Cognition Corp - ACOG Net earnings per share (EPS TTM)

Alpha Cognition Inc (ACOG) - corporate logo

The market for cognitive decline treatments possesses colossal potential, which can be tracked via the stock price trend on GURU.Markets, where the EPS stands at 30.90. The prosperity of Alpha Cognition (ACOG) relies on patents and the proven efficacy of dementia therapy. However, potential trial failures and pressure from corporate behemoths during regulatory reviews pose a serious threat.

Alpha Cognition Inc. - ACOG Net earnings per share (EPS TTM) (period 11/23/2025 - 11/12/2026)

Alpha Cognition Corp - analytical breakdowns and key metrics (ACOG)

- current price and projected stock value:
Price Performance Chart Alpha Cognition|ACOG - Analyst Consensus Forecast
- issuer market value details:
Market Capitalization Alpha Cognition Inc|ACOG - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value of a Share Alpha Cognition|ACOG - Book Capitalization|Market Cap to Net Assets Ratio alphacognition.com|ACOG - Aggregate Company Assets
- debt burden and liquidity indicators:
Debt to Capital Alpha Cognition|ACOG - Long-Term Debt to Capital|Short-Term Indebtedness to Equity Alpha Cognition|ACOG - Company Debts|Debt to Book Value Ratio Alpha Cognition Inc|ACOG - Company Long-Term Debts|Short-Term Debt Volume Alpha Cognition|Intermediate Liquidity Ratio alphacognition.com
- financial results and valuation multiples details:
ACOG - Net Profit|Company Profit Forecast Alpha Cognition|ACOG - Price to Earnings Ratio|Projected Price to Earnings Ratio Alpha Cognition|ACOG - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Alpha Cognition Inc|ACOG - Operating profit EBITDA|Net earnings per share (EPS TTM) Alpha Cognition|ACOG - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months alphacognition.com|ACOG - Earnings per share growth in current year|Expected net earnings per share growth next year Alpha Cognition
Initial company analysis:Alpha Cognition Inc., ACOG
Core merchandise of Alpha Cognition

Year-over-year (TTM) EPS growth measures the percentage change in net income per share over the last twelve months relative to the same period last year. This rolling-year EPS percentage change trend allows for an assessment of profit scaling rates. The calculation is based on a comparison of rolling quarterly data to neutralize seasonality. For Alpha Cognition (ACOG), this indicator will become key when launching the drug into the cognitive disorder treatment market.

Competitor analysis for Alpha Cognition

Earnings per share for the trailing year BIIB (biogen.com)|NBIX: Net earnings per share (EPS TTM)|Regencell Bioscience Ltd (RGC) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months AXSM|ACAD: Earnings per share for the trailing year|Net earnings per share (EPS TTM) XENE|Net earnings per share for the last 12 months vikingtherapeutics.com VKTX|Earnings per share for the last twelve months Supernus SUPN|Catalyst Pharma (CPRX) - Net earnings per one share for the last twelve months|Denali Therapeutics Inc - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Harmony Corp (HRMY)|Biohaven Ltd. (BHVN) - Earnings per share for the last twelve months|Earnings per share for the last 12 months AMLX|TRVI (Trevi Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Praxis Precision Medicines Inc (PRAX) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months AVXL (Anavex Corp)|Earnings per share for the last four quarters CBLL|Net earnings per share (EPS TTM) PRTA (Prothena Corporation)|Net earnings per share for the last four quarters Alector Inc. (ALEC)|ANNX - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Omeros Corporation|Neurogene Corp (NGNE) - Earnings per share for the last twelve months|Earnings per share for the last 12 months ACIU|VYGR (Voyager Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) neumoratx.com|Net earnings per share (EPS TTM) SCLX|Net earnings per share for the last 12 months Tevogen Bio Holdings Inc. TVGN|Earnings per share for the last twelve months Cognition Therapeutics CGTX|Inhibikase Pharma (IKT) - Net earnings per one share for the last twelve months|Cassava Sciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Assertio Holdings, Inc. (ASRT)|coyatherapeutics.com (COYA) - Earnings per share for the last twelve months|Earnings per share for the last 12 months VTGN|OVID (Ovid Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Acumen Pharmaceuticals, Inc ABOS|Net earnings per share for the last 12 months CRVO (CervoMed Inc.)|Net earnings per share (EPS TTM) alteritytherapeutics.com (ATHE)|Earnings per share for the last twelve months Clene CLNN|Earnings per share for the trailing year PEPG|JUNS - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Relmada Corp|ANVS: Net earnings per share (EPS TTM)|Grace Therapeutics (GRCE) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Firefly Neuroscience|Earnings per share for the last twelve months KLTO|Earnings per share for the last twelve months NeuroSense Therapeutics (NRSN)|RVPH: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) MTVA (MetaVia)|Earnings per share for the trailing year NRXS|Helius Medical Technologies Inc. - Net earnings per share (EPS TTM)|PASG - Net earnings per share (EPS TTM)|NEUP (bionomics.com.au) - Net earnings per share for the last 12 months|Minerva - Earnings per share for the trailing year|ATHA (Athira Pharma, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months addextherapeutics.com (ADXN)|Earnings per share for the last twelve months Alzamend Neuro, Inc. (ALZN)|CYCN - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) PTIX (Protagenic Therapeutics, Inc.)|Net earnings per share for the trailing year Pasithea Therapeutics Corp|CRGT - Earnings per share for the last twelve months|ATXI (avenuetx.com) - Earnings per share for the last 12 months|BCLI: Net earnings per share (EPS TTM)|CARA - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months CHRO|ELYM (Eliem) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) ITCI|Net earnings per share for the last four quarters longboardpharma.com|Earnings per share for the last twelve months Marinus Pharmaceuticals, Inc. MRNS|NKGen Biotech Inc (NKGN) - Net earnings per one share for the last twelve months|NRBO - Earnings per share for the last twelve months|SAGE (Sage Therapeutics Inc) - Earnings per share for the last 12 months|SNPX: Net earnings per share (EPS TTM)|trevena.com (TRVN) - Net earnings per share (EPS TTM)|VIGL (Vigil Neuroscience Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Anew Medical Inc. (WENA)|Earnings per share for the last twelve months Cerevel (CERE)